Metraipolis › archive › dc_80dd520f687b

Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW… — Europe PMC PMID:40982450

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40982450
DOI
10.1371/journal.pone.0323167
License (as archived)
solo-consultazione
Archived
2026-11-09T20:20:08.121Z
SHA-256 of the archived text
fc8eb00ab273fbe41a51c67057f09551e821fc70926b0b76bd4c9943e3a9f6f5
Stable URL of this page
https://metraipolis.com/documento/dc_80dd520f687b

How to cite

Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW… — Europe PMC PMID:40982450 — Europe PMC (en), https://europepmc.org/article/MED/40982450 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80dd520f687b (Metraipolis archive dc_80dd520f687b, sha256 fc8eb00ab273fbe41a51c67057f09551e821fc70926b0b76bd4c9943e3a9f6f5)
BibTeX
@misc{dc80dd520f687b,
  title = {Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW… — Europe PMC PMID:40982450},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40982450},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80dd520f687b; sha256 fc8eb00ab273fbe41a51c67057f09551e821fc70926b0b76bd4c9943e3a9f6f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40982450. Agents can read the archived copy with the MCP tool read_document.